Site Map Overview Welcome to Dechra Pharmaceuticals PLC Highlights Our Business and Strategy Our Group at a Glance Chairman's and Chief Executive Officer's Statement Our Business Model Our Marketplace Our Strategy How We Develop New Products Product Pipeline Key Products and Specialisations International Footprint People, Culture and Values Our Performance Financial Review Key Performance Indicators How the Business Manages Risk Q&A with Ian Page Q&A with Anne-Francoise Nesmes Q&A with Tony Griffin Q&A with Mike Eldred Strategy in Action Case Studies Our Governance Board of Directors Letter from the Chairman on Governance Corporate Governance Letter from the Audit Committee Chairman Audit Committee Report Letter from the Nomination Committee Chairman Nomination Committee Report Letter from the Remuneration Committee Chairman Directors' Remuneration Report Social, Ethical and Environmental Responsibilities Directors' Report - Other Disclosures Statement of Directors' Responsibilities Our Financials Independent Auditor's Report to the Members of Dechra Pharmaceuticals PLC Consolidated Income Statement Consolidated Statement of Comprehensive Income Consolidated Statement of Financial Position Consolidated Statement of Changes in Shareholders' Equity Consolidated Statement of Cash Flows Notes to the Consolidated Financial Statements Company Balance Sheet Reconciliation of Movements in Shareholders' Funds Notes to the Company Financial Statements Financial History Company Information Glossary Shareholder Information Advisers